This comprehensive guide for researchers, scientists, and drug development professionals details CRISPR-Cas technology, from its foundational biology to advanced clinical applications.
This comprehensive review for researchers, scientists, and drug development professionals analyzes the state of CRISPR-based clinical trials for genetic disorders in 2025.
This article provides a comprehensive 2025 analysis of the rapidly evolving CRISPR-Cas clinical trial landscape for researchers and drug development professionals.
This article provides a comparative analysis for research and drug development professionals of CRISPR-Cas9 gene editing versus its evolved counterpart, CRISPR base editing.
This article provides a comprehensive overview of CRISPR base editing, a revolutionary gene-editing technology that enables precise nucleotide conversions without creating double-strand DNA breaks (DSBs).
This article provides a detailed, current overview of CRISPR base editing technologies for precise correction of point mutations.
This article provides a comprehensive analysis of CRISPR-Cas systems as the adaptive immune defense mechanism in prokaryotes, targeting researchers, scientists, and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on the critical role of CRISPR amplification methods in profiling rare off-target editing events.
This article provides a comprehensive technical review for researchers and drug development professionals on the novel CRISPR delivery platform combining lipid nanoparticles (LNPs) with spherical nucleic acids (SNAs).
This comprehensive guide addresses the persistent challenge of low Homology-Directed Repair (HDR) efficiency in CRISPR-Cas9 genome editing.